Single-use Duodenoscope Market Driving ERCP Adoption

Single-use Duodenoscope Market Size, Shares and Key Players

The global single-use duodenoscope market size is calculated at USD 160.5 million in 2024, grew to USD 206.14 million in 2025, and is projected to reach around USD 1977.84 million by 2034. The market is expanding at a CAGR of 28.44% between 2025 and 2034.

The single-use duodenoscope market is primarily driven by the rising prevalence of gastrointestinal and pancreatic disorders. The changing hospital policies facilitate the demand for single-use duodenoscopes and reduce infection risk. Numerous key players develop innovative duodenoscopes to enhance patient comfort and simplify the procedure. Artificial intelligence (AI) transforms the design and manufacture of single-use duodenoscopes. The future looks promising, with the increasing use of 3D printing technology.

Key Takeaways

• Single-use duodenoscope sector pushed the market to USD 160.5 million by 2024.
• Long-term projections show USD 1977.84 million valuation by 2034.
• Growth is expected at a steady CAGR of 28.44% in between 2025 to 2034.
• North America held a major revenue share of approximately 44% the market in 2024.
• Asia-Pacific is expected to host the fastest-growing market in the coming years.
• By product type, the single-use duodenoscopes segment dominated the market with a share of approximately 72% in 2024.
• By product type, the reprocessing accessories & disposable components segment is expected to grow with the highest CAGR in the single-use duodenoscope market during the studied years.
• By procedure/application, the therapeutic ERCP segment led the market with a share of approximately 65% in 2024.
• By procedure/application, the diagnostic ERCP and cholangioscopy segment is expected to witness the fastest growth in the market over the forecast period.
• By end-user, the hospitals & tertiary care centers segment accounted for the highest revenue share of approximately 58% in the market in 2024.
• By end-user, the ambulatory surgery centers/outpatient endoscopy centers segment is expected to expand rapidly in the market in the coming years.
• By pricing/commercial model, the pre-procedure purchase segment registered its dominance over the global single-use duodenoscope market with a share of approximately 80% in 2024.
• By pricing/commercial model, the scope-as-a-service/managed supply contracts segment is expected to show the fastest growth over the forecast period.
• By feature/technology, the standard single-use imaging & working channel scopes segment contributed the biggest revenue share of the market in 2024.
• By feature/technology, the enhanced single-use platforms segment is expected to grow at the fastest CAGR in the market during the forecast period.

Quick Facts Table

Market Overview

The single-use duodenoscope market covers fully disposable (single-patient-use) duodenoscopes used to perform endoscopic retrograde cholangiopancreatography (ERCP) and related biliary/pancreatic diagnostic and therapeutic procedures. Single-use duodenoscopes eliminate the risk of reprocessing and reuse, reduce conce s about cross-contamination and infection transmission linked to complex reusable duodenoscope designs, and simplify logistics for low-volume or high-infection-risk settings. Infection-control priorities, regulatory guidance, hospital policy changes, cost-of-reprocessing considerations, increasing ERCP procedure volumes, and growing availability of commercial single-use devices with near-parity performance to reusable scopes drive adoption.

Single-use Duodenoscope Market Trends

• Favorable Regulatory Support: In April 2024, Ambu announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new-generation duodenoscopy solutions, Ambu aScope Duodeno 2 and Ambu aBox 2. The solutions were indicated for ERCP procedures.
• Boston Scientific Corporation is an American biotechnology company and a major manufacturer of medical devices. It offers the EXALT Model D Single-use Duodenoscope with ergonomic features similar to a reusable scope. The company generated net sales of $16.75 billion in 2024, an increase of 17.6%. The endoscopy segment generated the highest sales of $2.68 billion in 2024.

How Can AI Improve the Single-use Duodenoscope Market?

AI can revolutionize the design and manufacturing of single-use duodenoscopes, increasing efficiency and accuracy. It can help researchers develop novel and innovative duodenoscopes with enhanced safety and biocompatibility. It suggests a combination of materials, including elastic materials, recyclable plastics, and metal alloys, for developing strong duodenoscopes. Integrating AI into manufacturing potentiates speed and reproducibility. AI-based predictive analytics detects potential errors in manufacturing, enabling manufacturers to make proactive decisions.

Market Dynamics

Driver

Hospital-Associated Infections

The major growth factor for the single-use duodenoscope market is the increasing risk of hospital-associated infections (HAIs). Reusable duodenoscopes possess a higher chance of developing HAIs due to the possibility of inappropriate reprocessing. The World Health Organization (WHO) reported that around 1 in 10 patients are affected by HAIs. HAI is a serious health conce and leads to economic burden on the healthcare sector. In Europe, approximately 9 million HAIs are reported annually in acute and long-term care facilities, which lead to 25 extra hospital days and cost 13 to 24 billion euros. This potentiates the demand for single-use duodenoscopes in healthcare facilities.

Restraint

Increasing Medical Waste

Single-use duodenoscopes generate a large amount of medical waste, thereby significantly impacting the environment. They contribute to the hospital’s plastic waste problem and lead to an increased cost of their disposal. This limits the use of single-use duodenoscopes, hindering market growth.

Opportunity

What is the Future of the Single-use Duodenoscope Market?

The market future is promising, driven by the increasing use of 3D printing technology. 3D printing is emerging as an ideal technology for manufacturing customized medical devices. It can design and manufacture duodenoscopes based on patients’ conditions. The adoption of 3D printing is increasing due to numerous benefits, such as low cost and minimal production time. It generates less waste, complying with the regulatory policies. 3D printing allows the production of highly optimized parts with high accuracy and precision. The device manufactured from 3D printing can have higher flexibility, lower friction between the instrument and organ surface, and better torsional stiffness.

Segmental Insights

Which Product Type Segment Dominated the Single-use Duodenoscope Market?

By product type, the single-use duodenoscopes segment held a dominant presence in the market in 2024. This is due to the growing preference for single-use medical devices to prevent cross-contamination. The increasing incidences of HAIs and the use of cost-effective medical equipment potentiate the demand for single-use duodenoscopes. Reusable duodenoscopes require high capital investment due to higher operating expenses, unlike single-use duodenoscopes. Single-use duodenoscopes are highly preferred in high-risk individuals, such as immunocompromised patients.

By product type, the reprocessing accessories & disposable components segment is expected to grow at the fastest CAGR in the market during the forecast period. The reprocessing accessories & disposable components include trays, disposables, and other single-use accessories. They are essential components to be used along with duodenoscopes. This enhances safety in ERCP procedures. They are also discarded after use, eliminating the risk of contamination.

Why Did the Therapeutic ERCP Segment Dominate the Single-use Duodenoscope Market?

By procedure/application, the therapeutic ERCP segment held the largest revenue share of the market in 2024. This is due to the rising prevalence of bile duct stones and benign or malignant obstruction of the bile duct or pancreatic duct. ERCP is a procedure to diagnose and treat a blockage or restriction of the pancreatic or bile ducts. According to a multicenter observational study in Türkiye reported that a total of 66,993 ERCP procedures were performed in the surgical centers up to August 2024.

By procedure/application, the diagnostic ERCP and cholangioscopy segment is expected to grow with the highest CAGR in the market during the studied years. Single-use duodenoscopes are also used to diagnose problems within the pancreatic and bile ducts. The increasing demand for minimally invasive procedures necessitates healthcare professionals to use single-use duodenoscopes for diagnosing complications in the pancreatic and bile ducts.

How the Hospitals & Tertiary Care Centers Segment Dominated the Single-use Duodenoscope Market?

By end-user, the hospitals & tertiary care centers segment contributed the biggest revenue share of the market in 2024. The segmental growth is attributed to the presence of specialized infrastructure and suitable capital investments. Hospitals & tertiary care centers have professionals from multiple disciplines, providing multidisciplinary expertise to patients. Patients prefer hospitals due to favorable reimbursement policies.

By end-user, the ambulatory surgery centers/outpatient endoscopy centers segment is expected to expand rapidly in the market in the coming years. The demand for ambulatory surgery centers (ASCs) is increasing, as patients are not required to stay ove ight. ASCs and outpatient endoscopy centers have suitable facilities to conduct minimally invasive and non-invasive surgeries at affordable rates. They have specialized equipment and skilled professionals. Single-use duodenoscopes in ASCs reduce the need for on-site reprocessing and capital equipment.

What Made Pre-Procedure Purchase the Dominant Segment in the Single-use Duodenoscope Market?

By pricing/commercial model, the pre-procedure purchase segment accounted for the highest revenue share of the market in 2024. This segment dominated because hospitals prefer buying duodenoscopes based on the number of procedures performed. This helps hospitals to manage costs and avoid over-purchasing or over-storage of single-use duodenoscopes. It also avoids high capital investment to purchase bulk duodenoscopes. The per-procedure cost of a disposable duodenoscope in the U.S. ranges from $800 to $1500.

By pricing/commercial model, the scope-as-a-service/managed supply contracts segment is expected to witness the fastest growth in the market over the forecast period. Scope-as-a-service model is highly preferred by endoscopy centers and surgical clinics due to the increasing patient inflow for endoscopic procedures. They purchase duodenoscopes on a contract or subscription basis to avoid their shortage. This model reduces upfront capital burden and bundles disposables and waste management.

Which Feature/Technology Segment Led the Single-use Duodenoscope Market?

By feature/technology, the standard single-use imaging & working channel scopes segment led the global market in 2024. Duodenoscopes with 4-way tip control and standard optics are widely used. They enable side-viewing for accessing the bile and pancreatic ducts. They also include a working channel to accommodate endoscopic accessories, such as biopsy forceps and stents, for ERCP procedures. They possess a complex elevator mechanism to control the positioning and angle of accessories.

By feature/technology, the enhanced single-use platforms segment is expected to show the fastest growth over the forecast period. Enhanced single-use platforms are developed with advancements in technologies, such as cameras and sensors. They provide high-resolution imaging and improve the torque/control of duodenoscopes. They are integrated with advanced sensors, enhancing visual clarity. Additionally, they have wider therapeutic channels and disposability-optimized accessories.

Regional Analysis

Which Factors Contribute to the Single-use Duodenoscope Market in North America?

North America dominated the market share 44% in 2024. The presence of key players, favorable reimbursement policies, and favorable regulatory policies are the major growth factors for the market in North America. Hospitals and healthcare organizations in North America have a robust healthcare infrastructure, providing state-of-the-art care. Gove ment organizations support the development and use of single-use duodenoscopes.

U.S. Market Trends

Companies like Boston Scientific and Ottomed are the major providers of single-use duodenoscopes in various healthcare organizations in the U.S. The National Institute of Health (NIH) estimated that approximately 20 million gastrointestinal (GI) endoscopies are performed annually in the U.S.

Canada Market Trends

In June 2025, the Ontario gove ment announced an investment of $155 million over two years to deliver MRIs, CT scans, and GI endoscopy services across 57 new community surgical and diagnostic centers. This will help 1.2 million people to access publicly funded procedures faster.

Growing Need for Endoscopies Promotes Asia-Pacific

Asia-Pacific is expected to grow at the fastest CAGR in the single-use duodenoscope market during the forecast period. The increasing prevalence of pancreatic and bile-related disorders and the growing preference for minimally invasive surgeries bolster market growth. The increasing healthcare expenditure and the burgeoning healthcare sector contribute to market growth. The rising access to ERCP procedures owing to the growing adoption of advanced technologies propels the market. Increasing investments and collaborations among key players augment the market.

China Market Trends

The prevalence of gallstones in China is estimated to be 11%, imposing significant medical and economic burdens. A recent meta-analysis reported that the prevalence of HAIs in mainland China is approximately 3.12% in general hospitals. A 2024 study by researchers of the Naval Medical University found that the total number of endoscopic procedures increased from 28.8 million to 44.5 million from 2012 to 2019.

India Market Trends

In January 2024, Omega Healthcare and Sanjivani Gastro Liver Clinic brought AI-enabled endoscopy to Odisha for the diagnosis and treatment of GI disorders. Computer-assisted detection (CAD) technology will help the identification and treatment of cancerous, precancerous, and even non-cancerous lesions.

Value Chain Analysis of the Single-use Duodenoscope Market

R&D

R&D activities in single-use duodenoscopes include the development of scopes focusing on visualization, maneuverability, and ergonomics, with a strategic approach to best-in-class solutions.

Key Players: Olympus Corporation, Boston Scientific

Packaging & Sterilization

After manufacturing, duodenoscopes are packaged and sterilized to avoid microbial contamination. The sterile packaging is opened only prior to its use.

Key Players: Ambu A/S, Fujifilm Corporation

Distribution to Hospitals, Pharmacies

The sterilized duodenoscopes are distributed, either directly or with the help of distributors, to hospitals, ASCs, and pharmacies.

Key Players: Hugger Medical Instrument, B.Braun

Patient Support & Services

Single-use duodenoscopes ensure enhanced patient safety and improved patient outcomes by eliminating patient-to-patient contamination risk.

Top Companies in the Single-use Duodenoscope Market

• Boston Scientific
• Ambu A/S
• Olympus Corporation
• Fujifilm
• PENTAX Medical
• Karl Storz
• Cook Medical
• Richard Wolf
• Ottomed / SonoScape
• Huger Medical Instrument
• EndoFresh
• Micro-Tech
• Merit Medical
• STERIS / Cantel
• B. Braun

Latest Announcement by Industry Leaders

Britt Meelby Jensen, CEO of Ambu, commented that the company’s next-generation duodenoscope solution is a result of their close partnership with gastroenterologists. The company is dedicated to continuing its focused jou ey within GI, anchored in profound customer understanding as a pivotal driver for unlocking long-term potential – for gastroenterologists, patients, and Ambu.

Recent Developments in the Single-use Duodenoscope Market

• In September 2024, researchers from Zurich and Hong Kong developed a novel teleoperated robot system to perform endoscopic procedures. The remotely guided, magnetically steered robotic endoscope provides safer, less invasive, and performable even in remote regions short on trained personnel.
• In August 2024, the All India Institute of Medical Sciences (AIIMS), Jammu, announced the launch of the state-of-the-art Endoscopic Procedure Unit within the Department of Surgical Gastroenterology. The unit is equipped with advanced technology, allowing for minimally invasive procedures to enhance patient care and outcomes.

Segments Covered in the Report

By Product Type

• Single-use Duodenoscopes
• Reprocessing Accessories & Disposable Components

By Procedure/Application

• Therapeutic ERCP
• Diagnostic ERCP & Cholangioscopy
• High-risk/immunocompromised patient procedures

By End-User

• Hospitals & Tertiary Care Centers
• Ambulatory Surgery Centers/Outpatient Endoscopy Centers
• Small Clinics & Rural Hospitals
• Specialty Reference Centers

By Pricing/Commercial Model

• Per-Procedure Purchase
• Scope-as-a-Service/Managed Supply Contracts

By Feature/Technology

• Standard Single-use Imaging & Working Channel Scopes
• Enhanced Single-use Platforms

By Region 

• North America
  • U.S.
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait